Neurogene earnings were -$75.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest NGNE earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$19.5M, down 3.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NGNE reported annual earnings of -$75.1M, with 106.9% growth. The next NGNE earnings date is May 8, 2025.
On NGNE's earnings call on Invalid Date, Neurogene (NASDAQ: NGNE) reported Q4 2024 earnings per share (EPS) of -$0.99, up 96.66% year over year. Total NGNE earnings for the quarter were -$19.51 million. In the same quarter last year, Neurogene's earnings per share (EPS) was -$29.62.
The next NGNE earnings date is Invalid Date. Add NGNE to your watchlist to be reminded of Neurogene's next earnings date.
Is Neurogene profitable or losing money?
As of the last Neurogene earnings report, Neurogene is currently losing money. Neurogene's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$75.14 million, a 106.91% increase year over year.
What was NGNE's earnings growth in the past year?
As of Neurogene's earnings date in Invalid Date, Neurogene's earnings has grown year over year. NGNE earnings in the past year totalled -$75.14 million.
What are Neurogene's earnings expectations?
The current EPS estimate for Neurogene's earnings report in Invalid Date is -$1.12.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.